Involvement of spinal NADPH oxidase 4 and endoplasmic reticulum stress in morphine-tolerant rats

Xuyang Xiao1, Jingjie Yang1, Qian Bai1

  • 1Department of Anesthesiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Journal of Neurochemistry
|December 9, 2023
PubMed

Insights

Morphine tolerance involves spinal cord NOX4 activation, triggering endoplasmic reticulum stress and autophagy in GABAergic neurons. Targeting NOX4 and ER stress may prevent or treat morphine tolerance.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Morphine tolerance (MT) complicates intractable pain management.
  • Reactive oxygen species (ROSs) from NADPH oxidase (NOX) and endoplasmic reticulum (ER) stress are implicated in MT.
  • The specific NOX subtype initiating ER stress in MT remains unidentified.

Purpose of the Study:

  • To investigate the role of NOX4 in initiating ER stress during morphine tolerance.
  • To elucidate the mechanisms linking NOX4, ER stress, and autophagy in the spinal cord during MT.

Main Methods:

  • Utilized a classic morphine-tolerant rat model.
  • Assessed morphine's analgesic effect using the hot water tail-flick assay.
  • Analyzed spinal cord tissue for NOX4 expression, ER stress markers (PERK, IRE1, ATF6), and autophagy markers (LC3B, P62) in GABAergic neurons.

Main Results:

  • Chronic morphine administration upregulated spinal cord NOX4 expression.
  • NOX4 upregulation was mediated by the activation of three ER stress sensors: PERK, IRE1, and ATF6.
  • This process led to the activation of autophagy markers LC3B and P62 in GABAergic neurons.

Conclusions:

  • NOX4 activation initiates ER stress and subsequent autophagy in GABAergic neurons during morphine tolerance.
  • Targeting NOX4 and the ER stress/autophagy pathway presents a potential strategy for managing morphine tolerance.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
628
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
891
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
302